Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEET

v3.5.0.2
CONSOLIDATED BALANCE SHEET - USD ($)
May 31, 2016
Aug. 31, 2015
Current    
Cash and cash equivalents $ 37,102 $ 260,075
Accounts receivable 14,569 31,382
Inventory 126,774 167,986
Prepaid expenses and deposit 100,917 215,290
Total Current Assets 279,362 674,733
Patent 49,259 36,989
Property, plant and equipment 2,630 0
Total Non Current Assets 51,889 36,989
TOTAL ASSETS 331,251 711,722
Current    
Accounts payable and accrued liabilities 65,834 33,073
Unearned revenue 8,819 0
Due to related parties 256,883 22,052
Total Current Liabilities 331,536 55,125
Convertible debenture 45,000 0
TOTAL LIABILITIES 376,536 55,125
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 45,513,282 common shares at May 31, 2016 and 39,852,984 common shares at August 31, 2015 45,512 39,852
Additional paid-in capital 11,061,407 10,818,446
Deficit (10,986,229) (10,085,889)
Equity attributable to shareholders of the Company 120,690 772,409
Non-Controlling Interest (165,975) (115,812)
Total Stockholders' Equity (45,285) 656,597
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 331,251 $ 711,722